NantHealth, Inc. announced that a leading nonprofit multi-state health plan serving government-sponsored programs, signed a multi-year renewal using the NantHealthEviti Connect for Oncology platform. The agreement significantly expands the services and functionality beyond the current medical oncology offering to facilitate evidence-based radiation oncology care and better the member experience. Eviti Connect for Oncology has empowered oncology practices and health plans to prescribe and reimburse high-quality, high-value care for over ten years.

The automated process reduces the administrative burdens associated with obtaining and providing authorizations and ensures appropriate reimbursement, aligning payers and providers in their members' best interests. The agreement covers over two million members across six states and expands services to include: Radiation Therapy – Equipping radiation oncologists with radiation therapy validation using Eviti Connect for Oncology's comprehensive database of nationally recognized radiation therapies, expanding assurance of evidence-based medicine to the additional 20% of members who require radiation treatment. Care Navigation – Offering care navigation capabilities to members going through cancer treatment, guiding members through each step of the treatment journey, eliminating barriers to medication adherence, follow-up appointments, and diminishing caregiver and provider burdens.

Delegated Entity Services – Prior authorization determinations for treatment, and related provider and member communications, will be delegated to NantHealth, greatly reducing administrative time and costs typically associated with processing determinations. Application Programming Interface (API) Connections – Simplifying workflows by customizing systems to receive member treatment plan data directly from the Eviti Connect for Oncology platform, improving access to real-time data and reducing member care delays. NantHealth's Eviti Connect is a software-as-a-service (SaaS), evidence-based decision support and treatment plan validation platform that gives providers and payers confidence to prescribe and reimburse high-quality, high-value care.

It has helped payers and providers navigate the complexities of cancer care and autoimmune diseases to save time on appeals and expedite optimal patient care while managing payer costs.